STAT

Kennedy says he’ll act on legal challenge to ultra-processed foods

Health secretary Robert F. Kennedy Jr. fired the starting gun in a challenge to the food industry on Sunday, announcing on ...
STAT

Exit of CDC’s acting director highlights agency’s lack of leader

For 28 days last summer, the Centers for Disease Control and Prevention had a director who had been confirmed by the Senate. But in less time than it took Susan Monarez to get approved, she was fired ...
STAT

Major shakeup underway at HHS as White House braces for midterms

Several senior officials are exiting RFK Jr.'s department amid an effort to focus on drug pricing and food issues.
STATOpinion

America’s disease surveillance system is going dark. Here’s what we can build to replace it

That surveillance data was the nervous system of American medicine — constantly sensing, constantly warning us what was ...
STAT

Did the AMA change its position on surgery for transgender minors?

The AMA’s comment came in response to a recent position statement from the American Society of Plastic Surgeons that, while ...
STAT

In court, AAP argues Kennedy’s HHS made unlawful changes to vaccine policies

After a day of oral arguments in a packed courtroom, a Boston federal judge did not rule from the bench on a lawsuit from AAP ...
STAT

FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher

The FDA has rejected a rare disease therapy from Disc Medicine, an early recipient of a commissioner's voucher from the ...
STAT

FDA’s rejection of Moderna threatens to stifle broader vaccine industry

Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of ...
STAT

Secretive Project Prometheus takes VC Bob Nelsen beyond just health care

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
STAT

Moderna’s president weighs in on FDA’s decision not to review its flu vaccine

In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well ...
STAT

NIH redefines ‘clinical trials,’ dividing researchers

In a long-debated move, the NIH will no longer characterize basic experimental studies involving humans as clinical trials.
STAT

The FDA’s refusal to review Moderna’s mRNA flu vaccine

This week on "The Readout LOUD," everything you need to know about the FDA's controversial decision to block the review of ...